Stay updated with breaking news from Nasdaq rna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Profund Advisors LLC acquired a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 57,365 shares of the biotechnology company’s stock, valued at approximately $881,000. Other hedge funds and other institutional investors have also […] ....
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $7.65 and last traded at $7.70, with a volume of 205688 shares. The stock had previously closed at $7.97. Analysts Set New Price Targets Several brokerages recently commented on […] ....
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective […] ....
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned an average rating of “Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages […] ....
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target […] ....